L'Oréal's BOLD venture capital completed an investment in Timeline.

L'Oréal's strategic venture capital fund, BOLD completed an investment in Timeline, a Lausanne-based Swiss biotechnology company specializing in longevity research. Financial terms were not disclosed. This strategic collaboration reflects the breakthrough multidimensional approach that we've always believed is necessary to make meaningful advancements for longevity and healthspan," Patrick Aebischer, Timeline Co-Founder and Chairman.